Antimicrobial resistance of Actinobacillus pleuropneumoniae isolated from swine

Veterinary Microbiology

Volumn 156, Issue 1-2, 2012, Pages 172-177

  Vanni, Michele ^a   Merenda, Marianna ^b   Barigazzi, Giuseppe ^b   Garbarino, Chiara ^b   Luppi, Andrea ^b   Tognetti, Rosalba ^a   Intorre, Luigi ^a  

^a UNIVERSITY OF PISA   (Italy)

^b ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA LOMBARDIA E DELL EMILIA ROMAGNA   (Italy)

Author keywords

Actinobacillus pleuropneumoniae; Antimicrobial resistance; Italy; Swine; Trend

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFQUINOME; CEFTIOFUR; CHLORAMPHENICOL; COTRIMOXAZOLE; DANOFLOXACIN; ERYTHROMYCIN ESTOLATE; FLUMEQUINE; GENTAMICIN; LINCOMYCIN; MARBOFLOXACIN; PENICILLIN G; TILMICOSIN; TULATHROMYCIN;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BIOLOGICAL MONITORING; CONTROLLED STUDY; DISK DIFFUSION; INFECTION CONTROL; MEDICAL RECORD REVIEW; NONHUMAN; PORCINE PLEUROPNEUMONIA; RETROSPECTIVE STUDY; SWINE;

ACTINOBACILLUS INFECTIONS; ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALS; ANTI-BACTERIAL AGENTS; ITALY; MICROBIAL SENSITIVITY TESTS; PLEUROPNEUMONIA; RETROSPECTIVE STUDIES; SUS SCROFA; SWINE; SWINE DISEASES;

ACTINOBACILLUS PLEUROPNEUMONIAE; MYCOPLASMA; SUIDAE;

EID: 84857646338     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2011.10.022     Document Type: Article

References (35)

1. Aarestrup F.M., Jensen N.E. Susceptibility testing of Actinobacillus pleuropneumoniae in Denmark. Evaluation of three different media of MIC-determinations and tablet diffusion tests. Vet. Microbiol. 1999, 64:299-305.
2. Aarestrup F.M., Duran C.O., Burch D.G.S. Antimicrobial resistance in swine production. Anim. Health Res. Rev. 2008, 9:135-148.
3. Asawa T., Kobayashi H., Mitani K., Ito N., Morozumi T. Serotypes and antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from piglets with pleuropneumonia. J. Vet. Med. Sci. 1995, 57:757-759.
4. Bossé J.T., Janson H., Sheehan B.J., Beddek A.J., Rycroft A.N., Kroll J.S., Langford P.R. Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection. Microbes Infect. 2002, 4:225-235.
5. Burch D.G.S., Duran C.O., Aarestrup F.M. Guidelines for antimicrobial use in swine. Guide to Antimicrobial Use in Animals 2008, 102-125. Blackwell Publishing, Oxford, UK. L. Guardabassi, L.B. Jensen, H. Kruse (Eds.).
6. CASFM Comité de l'Antibiogramme de la Société Française de Microbiologie 2010, Communiqué. http://www.sfm-microbiologie.org/pages/?page=746%26id_page=182.
7. Chang C.F., Yeh T.M., Chou C.C., Chang Y.F., Chiang T.S. Antimicrobial susceptibility and plasmid analysis of Actinobacillus pleuropneumoniae isolated in Taiwan. Vet. Microbiol. 2002, 84:169-177.
8. Christensen H., Bisgaard M. Revised definition of Actinobacillus sensu strict isolated from animals. A review with special emphasis on diagnosis. Vet. Microbiol. 2004, 99:13-30.
9. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals 2008, CLSI M31-A3, Wayne, PA, USA.
10. Dubin D.T., Fitzgibbon J.E., Nahvi M.D., John J.F. Topoisomerase sequences of coagulase-negative staphylococcal isolates resistant to ciprofloxacin or trovafloxacin. Antimicrob. Agents Chemother. 1999, 43:1631-1637.
11. Fitzgibbon J.E., John J.F., Delucia J.L., Dubin D.T. Topoisomerase mutations in trovafloxacin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 1998, 42:2122-2124.
12. Gilbride K.A., Rosendal S. Antimicrobial susceptibility of 51 strains of Haemophilus pleuropneumoniae. Can. J. Comp. Med. 1984, 48:47-50.
13. Gottschalk M., Broes A., Mittal K.R., Kobisch M., Kuhnert P., Lebrun A., Frey J. Non-pathogenic Actinobacillus isolates antigenically and biochemically similar to Actinobacillus pleuropneumoniae: a novel species?. Vet. Microbiol. 2003, 92:87-101.
14. Gutiérrez-Martìn C.B., Garcìa del Blanco N., Blanco M., Navas J., Rodrìguez-Ferri E.F. Changes in antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Spain during the last decade. Vet. Microbiol. 2006, 115:218-222.
15. Haesebrouck F., Pasmans F., Chiers K., Maes D., Ducatelle R., Decostere A. Efficacy of vaccines against bacterial diseases in swine: what can we expect?. Vet. Microbiol. 2004, 100:255-268.
16. Hendriksen R.S., Mevius D.J., Schroeter A., Teale C., Jouy E., Butaye P., Franco A., Utinane A., Amado A., Moreno M., Greko C., Stärk K.D.C., Berghold C., Myllyniemi A.L., Hoszowski A., Sunde M., Aarestrup F.M. Occurrence of antimicrobial resistance among bacterial pathogens and indicator bacteria in pigs in different European countries from year 2002-2004: the ARBAO-II study. Acta Vet. Scand. 2008, 50:19-20.
17. Inoue A., Yamamoto K., Hirano N., Murakami T. Drug susceptibility of Haemophilus pleuropneumoniae strains isolated from pigs. Nippon Juigaku Zasshi 1984, 46:175-180.
18. Intorre L., Vanni M., Di Bello D., Pretti C., Meucci V., Tognetti R., Soldani G., Cardini G., Jousson O. Antimicrobial susceptibility and mechanism of resistance to fluoroquinolones in Staphylococcus intermedius and Staphylococcus schleiferi. J. Vet. Pharmacol. Ther. 2007, 30:464-469.
19. Jensen V.F., Jakobsen L., Emborg H.D., Seyfarth A.M., Hammerum A.M. Correlation between apramycin and gentamicin use in pigs and an increasing reservoir of gentamicin-resistant Escherichia coli. J. Antimicrob. Chemother. 2006, 58:101-107.
20. Kehrenberg C., Mumme J., Wallmann J., Verspohl J., Tegeler R., Kühn T., Schwarz S. Monitoring of florfenicol susceptibility among bovine and porcine respiratory tract pathogens collected in Germany during the years 2002 and 2003. J. Antimicrob. Chemother. 2004, 54:572-574.
21. Kim B., Min K., Choi C., Cho W.S., Cheon D.S., Kwon D., Kim.J., Chae C. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Korea using new standardized procedures. J. Vet. Med. Sci. 2001, 63:341-342.
22. Kucerova Z., Hradecka H., Nechvatalova K., Nedbalcova K. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolates from clinical outbreaks of porcine respiratory diseases. Vet. Microbiol. 2011, 150:203-206.
23. Matter D., Rossano A., Limat S., Vorlet-Fawer L., Brodard I., Perreten V. Antimicrobial resistance profile of Actinobacillus pleuropneumoniae and Actinobacillus porcitonsillarum. Vet. Microbiol. 2007, 122:146-156.
24. McEwen S.A., Fedorka-Cray P.J. Antimicrobial use and resistance in animals. Clin. Infect. Dis. 2002, 34(Suppl 3):S93-S106.
25. Morioka A., Asai T., Nitta H., Yamamoto K., Ogikubo Y., Takahashi T., Suzuki S. Recent trends in antimicrobial susceptibility and the presence of the tetracycline resistance gene in Actinobacillus pleuropneumoniae isolates in Japan. J. Vet. Med. Sci. 2008, 70:1261-1264.
26. Phillips J.E. Actinobacillus. Diagnostic Procedures in Veterinary Bacteriology and Mycology 1990, Academic Press, San Diego, CA, USA, pp. 143-149. G.R. Carter, J.R. Cole (Eds.).
27. Priebe S., Schwarz S. In vitro activities of florfenicol against bovine and porcine respiratory tract pathogens. Antimicrob. Agents Chemother. 2003, 47:2703-2705.
28. Ramjeet M., Deslandes V., Gouré J., Jacques M. Actinobacillus pleuropneumoniae vaccines: from bacterins to new insights into vaccination strategies. Anim. Health Res. Rev. 2008, 9:25-45.
29. Rycroft A.N., Garside L.H. Actinobacillus species and their role in animal disease. Vet. J. 2000, 159:18-36.
30. Salmon S.A., Watts J.L., Case C.A., Hoffman L.J., Wegener H.C., Yancey R.J. Comparison of MICs of ceftiofur and other antimicrobial agents against bacterial pathogens of swine from the United States, Canada, and Denmark. J. Clin. Microbiol. 1995, 33:2436-2444.
31. Salmon S., Portis E., Lindeman C. Minimum inhibitory concentrations for ceftiofur and comparator antimicrobial agents against bacterial pathogens of swine. Proceedings of the American Association of Swine Veterinarians Congress 2003, 235-239.
32. Sanders C.C. Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones. Clin. Infect. Dis. 2001, 32:S1-S8.
33. Shin S.J., Kang S.G., Nabin R., Kang M.L., Yoo A.S. Evaluation of the antimicrobial activity of florfenicol against bacteria isolated from bovine and porcine respiratory disease. Vet. Microbiol. 2005, 106:73-77.
34. Suzuki S., Ohmae K., Ohishi K., Muramatsu M., Takahashi T. Antimicrobial susceptibility of Actinobacillus (Haemophilus) pleuropneumoniae isolated from pigs with pleuropneumonia. Nippon Juigaku Zasshi 1989, 51:450-452.
35. Yoshimura H., Takagi M., Ishimura M., Endoh Y.S. Comparative in vitro activity of 16 antimicrobial agents against Actinobacillus pleuropneumoniae. Vet. Res. Commun. 2002, 26:11-19.